Neurocognitive and neuroradiologic central nervous system late effects in children treated on pediatric oncology group (POG) P9605 (Standard Risk) and P9201 (Lesser Risk) acute lymphoblastic leukemia protocols (ACCL0131): A methotrexate consequence? A report from the children's oncology group

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 1, 2014, Pages 8-15

  Duffner, Patricia K ^a   Armstrong, Floyd Daniel ^b   Chen, Lu ^c   Helton, Kathleen J ^d   Brecher, Martin L ^e   Bell, Beverly ^f   Chauvenet, Allen R ^g  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c CHILDREN S ONCOLOGY GROUP   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f Georgia Health Sciences Center   (United States)

^g WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Cognitive late effects; Methotrexate leukoencephalopathy; Unprotected intrathecal methotrexate (ITM)

Indexed keywords

METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ATTENTION; CANCER CHEMOTHERAPY; CANCER RISK; CHILD; CLINICAL PROTOCOL; COGNITION; CONSOLIDATION CHEMOTHERAPY; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; INTENSIVE CARE; INTERMETHOD COMPARISON; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIPLE INTRATHECAL THERAPY;

EID: 84891815316     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000000     Document Type: Article

References (26)

1. Gurney JG, Severson RK, Davis S, et al. Incidence of cancer in children in the United States: Sex, race, and 1 year agespecific rates. Cancer. 1995;75:2186-2195
2. Ganyon PS, Angiolillo AL, Carroll WL, et al. Long term results of the Children's Cancer Group studies for childhood acute lymphoblastic leukemia 1983-2002: A Children's Oncology Group Report. Leukemia. 2010;24:285-297
3. Salzer WL, Devidas M, Carroll WL, et al. Long-Term results of the Pediatric Oncology Group studies for childhood acute lymphoblastic leukemia 1984-2001: A report from the Children's Oncology Group. Leukemia. 2010;24:355-370
4. Peterson CC, Johnson CE, Ramirez LY, et al. A meta-Analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;51:99-104
5. Halsey C, Buck G, Richards S, et al. The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI. J Hematol Oncol. 2011;4:1-12
6. Shuper A, Stark B, Kornreich L, et al. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia. Isr Med Assoc J. 2002;4:1050-1053
7. Peylan-Ramu N, Poplack DG, Pizzo PA, et al. Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med. 1978;298:815-819
8. Ochs JJ, Berger P, Brecher ML, et al. Computed tomography brain scans in children with acute lymphocytic leukemia receiving methotrexate alone as central nervous system prophylaxis. Cancer. 1980;45:2274-2278
9. Brown RT, Madan-Swain A, Walco GA, et al. Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. J Pediatr Psychol. 1998;23:333-340
10. Mahoney DH, Shuster JJ, Nitschke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy-A Pediatric Oncology Group study. J Clin Oncol. 1998;16:1712-1722
11. Chauvenet AR, Martin PL, Devidas M, et al. Anti-metabolite therapy for lesser risk B-lineage acute lymphoblastic leukemia of childhood: A report from Children's Oncology Group Study P9201. Blood. 2007;110:1105-1111
12. Reddick WE, Glass JO, Helton KJ, et al. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. Am J Neuroradiol. 2005;26:1263-1269
13. Chu WCW, Chik K, Chan Y, et al. White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: Longitudinal study with MR imaging and 1 H MR spectroscopy. Radiology. 2003;229: 650-669
14. Wilson DA, Nitschke R, Bowman ME, et al. Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: Correlation with neuropsychologic deficiencies. Radiology. 1991;180:205-209
15. Montour-Proulx I, Kuehn SM, Keene DL, et al. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol. J Child Neurol. 2005;20:129-133
16. Anderson FS, Kunin-Batson AS. Neurocognitive late effects of chemotherapy in children: The past 10 years of research on brain structure and function. Pediatr Blood Cancer. 2009;52:159-164
17. Buizer AI, de Sonneville LMJ, Veerman AJP. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: A critical review of the literature. Pediatr Blood Cancer. 2009;52:447-454
18. Campbell LK, Scaduto M, Sharp W, et al. A meta-Analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2007;49:65-73
19. Kadan-Lottick NS, Brouwers P, Breiger D, et al. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. Blood. 2009;114: 1746-1752
20. Lofstad GE, Reinfjell T, Hestad K, et al. Cognitive outcome in children and adolescents treated for acute lymphoblastic leukemia with chemotherapy only. Acta Paediatr. 2009;98: 180-186
21. Mennes M, Stiers P, Vandenbussche E, et al. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr Blood Cancer. 2005;44:479-486
22. Buizer AI, de Sonneville LMJ, van den Heuvel-Eibrink MM, et al. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: Effect of treatment intensity. Pediatr Blood Cancer. 2005;45:281-290
23. Kadan-Lottick NS, Brouwers P, Breiger D, et al. Comparison of neuro-cognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of acute lymphoblastic leukemia. J Clin Oncol. 2009;27:5986-5992
24. Cole PD, Kamen BA. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Mental Retard Dev Disabil Res Rev. 2006;12:174-183
25. Ashley DM, Merchant TE, Strother D, et al. Induction chemotherapy and conformal radiation for very young children with non-metastatic medulloblastoma: P9934 A Children's Oncology Group study. J Clin Oncol. 2012;30: 3181-3186
26. Waber DP. More good news about neuropsychological late effects in long-Term survivors of acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2002;24:86-87